Ibnsina to inject EGP150-200mn in investments in 2018; targeting 26% market share over next five years
Ibnsina Pharma [IBNP.CA] announced plans to invest EGP150-200mn in 2018, aimed at expanding its distribution network and adding more branches, according to the company’s CEO, Omar Abdel Gawad. The pharmaceuticals distributor is targeting a 26% market share over the next five years, as opposed to a current market share of 19.3%, Abdel Gawad added. Ibnsina recorded sales of EGP1bn from government tenders in 2017 and is targeting a further increase over the next five years on the back of an increased government interest in the sector
This website uses cookies to make the site work, to understand if the site is working well, how it is being used, to connect to social media sites (such as Facebook and Twitter) and to collect information useful to allow us and our partners to provide you with more relevant ads . Some cookies are essential to make the site work, but you can control how we use non-essential cookies at any time by clicking the “ON/OFF” button next to each category. For more information about the cookies used on this site, see Privacy Policy.
Decide which cookies you want to allow.
Strictly Necessary
These cookies are essential in order to enable you to move around our website and use its features, such as accessing secure areas of our website. Without these cookies, any services on our Site you wish to access cannot be provided.
Analytical/performance cookies
Visitors use our website, for instance which pages you go to most often, and if you get error messages from web pages.